Tuberculosis Research and Treatment / 2021 / Article / Tab 2

Research Article

Treatment Outcomes and Associated Factors in Tuberculosis Patients at Atwima Nwabiagya District, Ashanti Region, Ghana: A Ten-Year Retrospective Study

Table 2

TB treatment regimen.

Patient categoryDefinitionInitial phase treatmentContinuous phase treatment
Daily (28 doses/month)Daily (28 doses/month)

All new clientsNew smear-positive of HRZE doses of HR
New smear-negative pulmonary TB
Concomitant HIV disease
Extrapulmonary TB

Previously treated sputum smear-positive pulmonary TBRelapse doses of HRE
Treatment after interruption
Treatment failure

ChildrenªChildren below 12 years doses of HRZ doses of HR

Direct observation of treatment intake is required and always in regimen including rifampicin. ¥Streptomycin may be used instead of ethambutol. In meningitis, ethambutol should be replaced by streptomycin. ªIn children with meningitis, add streptomycin in the initial phase. Codes for Tb drugs: H: isoniazid; R: rifampicin; Z: pyrazinamide; S: streptomycin; E: ethambutol. Fixed drug combinations (FDC) codes: (HR): isoniazid + rifampicin; (HRZ): isoniazid + rifampicin + pyrazinamide; (HRZE): isoniazid + rifampicin + pyrazinamide + ethambutol.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.